Intratumoral Cancer Therapies Market

Intratumoral Cancer Therapies Market Global Scenario, Market Size, Outlook, Trend, and Forecast, 2019 – 2028



Cancer is a leading cause of global death, which nearly caused 10 million deaths in 2020. The treatment of cancer typically includes chemotherapy, hormone therapy, immunotherapy, gene therapy, radiotherapy, and targeted therapy. However, in some of the cases, patients do not respond to any of the available treatment options or develop resistance to available therapies. This creates a lacuna, which in turn creates an opportunity for the scientific community to develop a keen interest in Intratumoral Cancer Therapies that are immunotherapy's and the immunization is administered directly into tumor's through injections. By filling this lacuna of cancer treatment, immunotherapy has evolved and had come a long way with its benefits and possesses advantages over conventional cancer treatment methods, which is widely accepted. sales@accurizemarketresearch.com Copyright © 2021 Accurize Market Research

MARKET DYNAMICS



According to an estimate, 19,292,789 new cancer cases were diagnosed worldwide with nearly 9,958,133 deaths due to cancers. Additionally, according to estimates from the International Agency for Research on Cancer (IARC), by 2040, the global burden of cancers is expected to continuously grow to 27.5 million new cancer cases and 16.3 million deaths worldwide. This rapid increment in the incidence of cancer cases is predicted to drive the demand for advanced cancer therapies for the effective treatment of patients worldwide. Thus, according to the above-mentioned factors, the cancer therapy as well as intratumoral cancer therapies market is predicted to witness tremendous growth over the forecast period. sales@accurizemarketresearch.com Copyright © 2021 Accurize Market Research

REGIONAL INSIGHTS



In contemporary times, North America currently dominates the Cancer Therapy Market and is expected to continue during the forecast period. In the future, North America is expected to acquire more market share in the market due to increased adoption of cancer therapy .According to the report of GLOBOCAN 2020, an estimated 2,281,658 new cancer cases were diagnosed in the United States in 2020, with nearly 612,390 deaths. In USA, the most common cancers were breast (253,465), lung (227,875, colon (101,809) and prostate (209,512) when observed in the year 2020. The statistics of the referred market predict a positive outcome for the upcoming investment in this field. sales@accurizemarketresearch.com Copyright © 2021 Accurize Market Research

SEGMENTATION OF INTRATUMORAL CANCER THERAPIES MARKET 

There are different categories of Intramoral therapies ranging from cytokines, pathogen-associated molecular patterns (PAMPs), oncolytic viruses, monoclonal antibodies, and small molecules. The present Intratumoral cancer therapy market comprises of three approved therapies:



Imlygic (talimogene laherparepvec; T-Vec) approved by FDA(USA) to treat melanoma



Hensify (NBTXR3) for the treatment of patients suffering from soft tissue sarcoma



Delytact(teserpaturev) for the treatment of malignant glioma The intratumoral cancer therapies market has registered the highest growth in North America during the past few years and this progressive trend is expected to continue in the forthcoming years as well. This is a result of the growing geriatric population. sales@accurizemarketresearch.com Copyright © 2021 Accurize Market Research

LEADING MARKET PLAYERS IN THE INDUSTRY



Some of the key/prominent /major players operating in the Intratumoral Cancer market are Checkmate Pharmaceuticals, OncoSec Medical Incorporated, Merck, Istari Oncology, Replimune, Philogen, Exicure, Sirnaomics, Nanobiotix, Intensity Therapeutics, NanOlogy, Lokon Pharma, Immunicum, DNAtrix, Treovir, Idera Pharmaceuticals, and Immunovative Therapies among others. These companies are working in the contemporary times for the development of Intratumoral cancer therapies at different stages of clinical trials; thereby boosting the competition in the Intratumoral cancer market. The emerging Intratumoral cancer therapies pipeline is majorly curing melanoma, brain cancer, nonmelanoma skin cancer, head, and neck cancer. sales@accurizemarketresearch.com Copyright © 2021 Accurize Market Research

SCOPE AND SEGMENTATION OF INTRATUMORAL CANCER THERAPIES MARKET  

BASED ON PRODUCT Drugs Opioids Non-steroidal anti-inflammatory drugs (NSAIDs) Anticonvulsants Antidepressants

› › › › 

Devices Neurostimulation devices

›  

Spinal cord stimulation (SCS) devices Transcutaneous electrical nerve stimulation (TENS) devices

Analgesic infusion pumps Ablation devices

› ›  

Radiofrequency ablation devices Cryoablation devices sales@accurizemarketresearch.com

      

BASED ON INDICATION Neuropathic Pain Arthritis Pain Chronic Back Pain Cancer Pain Migraine Fibromyalgia

BASED ON END USER oHospitals oClinics oNursing Homes oResearch Centers & Universities

BASED ON APPLICATION  Neuropathy  Oncology  Musculoskeletal 

 



GEOGRAPHICAL ANALYSIS North America › U.S. › Canada Europe › Germany › France › U.K. › Italy › Spain › Netherlands › Russia › Sweden › Switzerland › Rest of Europe Asia-Pacific (APAC) › Japan › China › India › Australia › South Korea › Rest of APAC Latin America (LATAM) › Brazil › Mexico Middle East & Africa (MEA) › Saudi Arabia › South Africa

LEADING MARKET PLAYERS OF INTRATUMORAL CANCER THERAPIES MARKET oELI LILLY AND COMPANY oGlaxoSmithKnile plc oPfizer Inc. oMedtronic plc oAbott Laboratories oBoston Scientific Corporation oNovartis AG oJhonson & Jhonson oAstraZeneca plc oBristol-Myers Squibb Company oBectojn,Dickinson and Company oSanofi S.A.

Contact us : Accurize Market Research Pvt. Ltd. PATNA OFFICE: K-129, PC COLONY, HANUMAN NAGAR, KANKARBAGH, PATNA, PIN-800020 Email:help@accurizemarketresearch.com CONTACT NO:+1-339-368-6383

Turn static files into dynamic content formats.

Create a flipbook

Intratumoral Cancer Therapies Market

Published on Nov 3, 2021

priya

Cancer is a leading cause of global death, which nearly caused 10 million deaths in 2020. The treatment of cancer typically includes chemotherapy, hormone therapy, immunotherapy, gene therapy, radiotherapy, and targeted therapy. However, in some of the cases, patients do not respond to any of the available treatment options or develop resistance to available therapies. This creates a lacuna, which in turn creates an opportunity for the scientific community to develop a keen interest in Intratumoral Cancer Therapies that are immunotherapies and the immunization is administered directly into tumour’s through injections. By filling this lacuna of cancer treatment, immunotherapy has evolved and had come a long way with its benefits and possesses advantages over conventional cancer treatment methods, which is widely accepted.